Opportunity Assessment
Manage and track optimization opportunities
| ID | Type | Description | Vendor | Est. Value | Confidence | Status | Assigned To | Created | ||
|---|---|---|---|---|---|---|---|---|---|---|
| OPP-2024-001 | Tier Upgrade | Upgrade Cardinal Health volume program to Platinum tier | Cardinal Health | $125,000 | High | Recommended |
SJ
Sarah J.
|
Nov 15 | ||
| OPP-2024-002 | Customer Exp | Add 12 customers to McKesson rebate program | McKesson | $98,000 | High | Approved |
MC
Mike C.
|
Nov 12 | ||
| OPP-2024-003 | Product Exp | Expand Pfizer rebate to include oncology products | Pfizer | $87,000 | Medium | In Analysis |
ER
Emily R.
|
Nov 10 | ||
| OPP-2024-004 | Renewal | Renegotiate AmerisourceBergen contract with improved rates | AmerisourceBergen | $76,000 | High | New | Unassigned | Nov 8 | ||
| OPP-2024-005 | New Contract | New rebate program with Medline for surgical supplies | Medline | $65,000 | Medium | In Analysis |
SJ
Sarah J.
|
Nov 5 | ||
| OPP-2024-006 | Consolidation | Consolidate Q4 purchases for Johnson & Johnson tier bump | Johnson & Johnson | $54,000 | Low | In Progress |
MC
Mike C.
|
Nov 1 |
Showing 1-6 of 47 opportunities
New
4 | $312K
OPP-2024-004
High
Renegotiate AmerisourceBergen contract
Renewal
$76K
OPP-2024-007
Med
Add specialty products to Baxter program
Product
$45K
In Analysis
12 | $620K
OPP-2024-003
Med
Expand Pfizer rebate to oncology
Product
$87K
ER
OPP-2024-005
Med
New Medline surgical supplies program
New
$65K
SJ
Recommended
8 | $480K
OPP-2024-001
High
Upgrade Cardinal Health to Platinum
Tier
$125K
SJ
Approved
6 | $340K
OPP-2024-002
High
Add 12 customers to McKesson
Customer
$98K
MC
In Progress
3 | $180K
OPP-2024-006
Low
Consolidate J&J Q4 purchases
Consolidation
$54K
MC
Pipeline visualization will show opportunity flow and conversion metrics
| ID | Type | Description | Vendor | Realized Value | Outcome | Closed Date |
|---|---|---|---|---|---|---|
| OPP-2024-021 | Tier Upgrade | Abbott tier upgrade to Gold | Abbott Laboratories | $145,000 | Realized | Oct 28 |
| OPP-2024-019 | Customer Exp | Expand customer base for Merck vaccines | Merck | $89,000 | Realized | Oct 15 |
| OPP-2024-017 | Renewal | Renewed Baxter contract with improved terms | Baxter International | $112,000 | Realized | Oct 5 |
| OPP-2024-015 | New Contract | New program with BD - Not pursued | Becton Dickinson | $0 | Dismissed | Sep 28 |
Total Realized Value (YTD): $1,847,000
Success Rate: 78% (23 of 29 opportunities)